1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NRX PHARMACEUTICALS INC

NRX Pharmaceuticals Inc

XNAS: NRXP

Download real time

2.04 0.10 (5.15%)

66.06% Fall from 52W High

110.9K XNAS Volume

XNAS 02 Apr, 2025 2:35 PM (EDT)

Watchlist

Portfolio

Share
9S
6W
2O
1T
34.5

Market Cap

Below industry Median
-1.4

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
-1.8

Price to Book

Negative Price to Book
-0.3

Beta 1Year

Very Low volatility


Insider Trading disclosures for NRX Pharmaceuticals Inc

The latest disclosure was made by Michael Abrams in NRX Pharmaceuticals Inc where a trade of 50,000 Stock Option (right to buy) done was reported to US exchanges on Feb. 7, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michael Abrams Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 50,000 50,000 - - Stock Option (right to buy)
Jonathan C. Javitt Director, Chairman and Chief Scientist, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.17 per share. 17 Dec 2024 40,000 84,634 - 1.2 46,800 Common Stock
Jonathan C. Javitt Director, Chief Scientist, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.33 per share. 23 Aug 2023 100,000 446,332 - 0.3 33,000 Common Stock
Jonathan C. Javitt Director, Chief Scientist, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.32 per share. 22 Aug 2023 200,000 346,332 - 0.3 64,400 Common Stock
Jonathan C. Javitt Director, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2022 300,000 14,468,329 - 0 Common Stock, par value $0.001 per share
Stephen H. Willard Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 1.17 per share. 16 Dec 2022 50,000 50,000 - 1.2 58,500 Common Stock, par value $0.001 per share
Jonathan C. Javitt Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.00 per share. 07 Dec 2022 400,000 12,899,997 - 1 400,000 Common Stock, par value $0.001 per share
Patrick J. Flynn Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 28 Nov 2022 2,500 40,209 - 1.3 3,125 Common Stock, par value $0.001 per share
Patrick J. Flynn Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 28 Nov 2022 2,500 37,709 - 1.3 3,125 Common Stock, par value $0.001 per share
Patrick J. Flynn Director Purchase of securities on an exchange or from another person at price $ 1.24 per share. 28 Nov 2022 2,500 40,209 - 1.2 3,100 Common Stock, par value $0.001 per share
Patrick J. Flynn Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 28 Nov 2022 1,750 1,750 - 1.3 2,188 Common Stock, par value $0.001 per share
Patrick J. Flynn Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 28 Nov 2022 2,500 37,709 - 1.3 3,125 Common Stock, par value $0.001 per share
Aaron Gorovitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 162,660 162,660 - - Employee Stock Option
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 162,660 162,660 - - Employee Stock Option
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2022 162,660 228,097 - - Employee Stock Option
Chaim Hurvitz Director Purchase of securities on an exchange or from another person at price $ 1.10 per share. 21 Oct 2022 40,408 500,000 - 1.1 44,449 Common Stock
Chaim Hurvitz Director Purchase of securities on an exchange or from another person at price $ 0.99 per share. 21 Oct 2022 287,812 287,812 - 1.0 284,934 Common Stock
Chaim Hurvitz Director Purchase of securities on an exchange or from another person at price $ 1.08 per share. 21 Oct 2022 171,780 459,592 - 1.1 185,522 Common Stock
Jonathan C. Javitt Director, Chief Scientist, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.58 per share. 01 Jun 2022 100,000 146,332 - 0.6 58,000 Common Stock
Robert Besthof Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2022 100,000 347,200 - - Employee Stock Option
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2021 7,502 33,603 - - Restricted Stock Units
Alessandra Daigneault General Counsel & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. 19 Aug 2021 27,395 33,715 - 3.1 84,103 Common Stock
Alessandra Daigneault General Counsel & Secretary Sale of securities on an exchange or to another person at price $ 13.11 per share. 19 Aug 2021 33,715 0 - 13.1 442,004 Common Stock
Alessandra Daigneault General Counsel & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. 19 Aug 2021 18,420 18,420 - 3.1 56,549 Common Stock
Alessandra Daigneault General Counsel & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.07 per share. 19 Aug 2021 13,164 31,584 - 3.1 40,413 Common Stock
Alessandra Daigneault General Counsel & Secretary 19 Aug 2021 43,000 100,840 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2021 15,605 15,605 - - Restricted Stock Units
Alessandra Daigneault General Counsel & Secretary 19 Aug 2021 28,916 71,924 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary 19 Aug 2021 20,666 28,934 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2021 10,496 26,101 - - Restricted Stock Units
Robert Besthof Chief Comm. & Patient Officer Sale of securities on an exchange or to another person at price $ 11.76 per share. 16 Aug 2021 40,000 23,710 - 11.8 470,400 Common Stock
Robert Besthof Chief Comm. & Patient Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2021 36,290 36,290 - - Restricted Stock Units
Robert Besthof Chief Comm. & Patient Officer 16 Aug 2021 100,000 247,200 - - Employee Stock Option (Right to buy)
Robert Besthof Chief Comm. & Patient Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.20 per share. 16 Aug 2021 63,710 63,710 - 0.2 12,742 Common Stock
Chaim Hurvitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 218,423 218,423 - - Common Stock Warrant (Right to buy)
Jonathan C. Javitt Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 13,348,997 13,348,997 - - Common Stock
Jonathan C. Javitt Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 1,422,000 1,422,000 - - Common Stock
Jonathan C. Javitt Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 46,332 46,332 - - Common Stock
Chaim Hurvitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 1,436,350 1,436,350 - - Common Stock
Chaim Hurvitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 208,443 208,443 - - Common Stock
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 362,332 362,332 - - Common Stock
Robert Besthof Chief Comm. & Patient Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 347,200 347,200 - - Employee Stock Option (Right to buy)
Robert Besthof Chief Comm. & Patient Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 347,200 347,200 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 49,600 49,600 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 6,320 6,320 - - Common Stock
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 143,840 143,840 - - Employee Stock Option (Right to buy)
Alessandra Daigneault General Counsel & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 148,800 148,800 - - Employee Stock Option (Right to buy)
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 13,168 13,168 - - Common Stock
Sharon A. Glied Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 65,437 65,437 - - Employee Stock Option (Right to buy)
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 35,209 35,209 - - Common Stock
William Fricker CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 99,200 99,200 - - Employee Stock Option (Right to buy)
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 692,639 692,639 - - Common Stock Warrant (Right to buy)
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 692,639 692,639 - - Common Stock Warrant (Right to buy)
Patrick J. Flynn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 35,209 35,209 - - Common Stock
Aaron Gorovitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 8,336 8,336 - - Common Stock
Aaron Gorovitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 8,336 8,336 - - Common Stock
Aaron Gorovitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 16,678 16,678 - - Common Stock
Aaron Gorovitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 8,336 8,336 - - Common Stock
William Fricker CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2021 99,200 198,400 - - Employee Stock Option (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters